Nexstim Plc (NXTMH.HE)
EUR 8.1
(0.5%)
EUR 8.1
(0.5%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.19 Million EUR | 35.64% |
| 2022 | 1.36 Million EUR | 107.79% |
| 2021 | 657.54 Thousand EUR | 119.73% |
| 2020 | -3.33 Million EUR | 48.86% |
| 2019 | -6.51 Million EUR | -3.2% |
| 2018 | -6.31 Million EUR | -12.94% |
| 2017 | -5.59 Million EUR | 16.49% |
| 2016 | -6.69 Million EUR | 35.43% |
| 2015 | -10.36 Million EUR | -32.95% |
| 2014 | -7.79 Million EUR | -75.87% |
| 2013 | -4.43 Million EUR | -69.41% |
| 2012 | -2.61 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -864.2 Thousand EUR | 0.0% |
| 2023 FY | 1.85 Million EUR | 35.64% |
| 2023 Q2 | -1.38 Million EUR | -100.01% |
| 2023 Q3 | 96.82 Thousand EUR | 106.98% |
| 2023 Q1 | -693.55 Thousand EUR | 53.55% |
| 2023 Q4 | 159.2 Thousand EUR | 64.42% |
| 2022 Q3 | -746.54 Thousand EUR | -132.0% |
| 2022 Q4 | -1.49 Million EUR | -99.99% |
| 2022 Q2 | 2.33 Million EUR | 99.99% |
| 2022 FY | 1.36 Million EUR | 107.79% |
| 2022 Q1 | 1.16 Million EUR | 258.78% |
| 2021 Q2 | -902.8 Thousand EUR | -100.02% |
| 2021 FY | 657.54 Thousand EUR | 119.73% |
| 2021 Q4 | -734.8 Thousand EUR | -167.44% |
| 2021 Q3 | -274.75 Thousand EUR | 69.57% |
| 2021 Q1 | -451.35 Thousand EUR | 69.83% |
| 2020 Q3 | -748.15 Thousand EUR | 59.26% |
| 2020 Q2 | -1.83 Million EUR | -100.0% |
| 2020 Q1 | -918.2 Thousand EUR | 70.9% |
| 2020 FY | -3.33 Million EUR | 48.86% |
| 2020 Q4 | -1.49 Million EUR | -99.96% |
| 2019 Q3 | -1.57 Million EUR | 53.07% |
| 2019 FY | -6.51 Million EUR | -3.2% |
| 2019 Q1 | -1.68 Million EUR | 6.11% |
| 2019 Q2 | -3.36 Million EUR | -100.0% |
| 2019 Q4 | -3.15 Million EUR | -100.0% |
| 2018 Q1 | -1.36 Million EUR | 12.01% |
| 2018 FY | -6.31 Million EUR | -12.94% |
| 2018 Q4 | -1.79 Million EUR | 0.0% |
| 2018 Q2 | -1.36 Million EUR | 0.0% |
| 2018 Q3 | -1.79 Million EUR | -30.93% |
| 2017 Q3 | -1.55 Million EUR | -25.14% |
| 2017 FY | -5.59 Million EUR | 16.49% |
| 2017 Q2 | -1.24 Million EUR | 0.0% |
| 2017 Q1 | -1.24 Million EUR | 3.87% |
| 2017 Q4 | -1.55 Million EUR | 0.0% |
| 2016 Q2 | -2.05 Million EUR | 0.0% |
| 2016 Q4 | -1.29 Million EUR | 0.0% |
| 2016 FY | -6.69 Million EUR | 35.43% |
| 2016 Q3 | -1.29 Million EUR | 37.17% |
| 2016 Q1 | -2.05 Million EUR | 24.45% |
| 2015 Q4 | -2.72 Million EUR | 0.0% |
| 2015 Q3 | -2.72 Million EUR | -10.48% |
| 2015 FY | -10.36 Million EUR | -32.95% |
| 2015 Q1 | -2.46 Million EUR | -4.93% |
| 2015 Q2 | -2.46 Million EUR | 0.0% |
| 2014 Q3 | -2.34 Million EUR | -51.25% |
| 2014 FY | -7.79 Million EUR | -75.87% |
| 2014 Q4 | -2.34 Million EUR | 0.0% |
| 2014 Q2 | -1.55 Million EUR | 0.0% |
| 2014 Q1 | -1.55 Million EUR | -64.18% |
| 2013 Q3 | -945.41 Thousand EUR | 25.67% |
| 2013 Q4 | -945.41 Thousand EUR | 0.0% |
| 2013 Q2 | -1.27 Million EUR | 0.0% |
| 2013 FY | -4.43 Million EUR | -69.41% |
| 2013 Q1 | -1.27 Million EUR | -88.51% |
| 2012 FY | -2.61 Million EUR | 0.0% |
| 2012 Q1 | -674.74 Thousand EUR | 0.0% |
| 2012 Q2 | -674.74 Thousand EUR | 0.0% |
| 2012 Q3 | -674.74 Thousand EUR | 0.0% |
| 2012 Q4 | -674.74 Thousand EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| BBS-Bioactive Bone Substitutes Oyj | -3.36 Million EUR | 64.551% |
| Modulight Oyj | -12.13 Million EUR | 90.163% |
| Revenio Group Oyj | 26.34 Million EUR | 104.53% |